Expression of human FXN upon intravenous injection of an AAV-FXN vector in the mouse model extended lifespan, improved cardiac function and prevented peripheral sensory neuropathy (Gerard et al., 2014; Perdomini et al., 2014; Piguet et al., 2018). The gene discussed is FXN; the disease is sensory peripheral neuropathy.